| pubmed-article:1872641 | pubmed:abstractText | As of July 1, 1991, HCFA will reimburse for Epoetin alfa self-administered by home-based dialysis patients. Implications of this change, including the impact on patients and the changes that will be required to assure effective nursing assessment and optimal patient management, are reviewed. | lld:pubmed |
